Rapid Plasma Reagin Test Market to observe USD 46.28 Mn incremental growth -- Driven by increasing incidence of syphilis

NEW YORK, Sept. 20, 2022 /PRNewswire/ -- The "

Rapid Plasma Reagin Test Market by Test and Geography - Forecast and Analysis 2022-2026" report has been added to Technavio's offering. The report expects the market size to grow by USD 46.28 million, accelerating at a CAGR of 4.26 between 2021 and 2026. The report considers various aspects such as the consumer base, adoption rate, average selling price, revenue generated by vendors, and various other factors to estimate the market size.

Download Sample PDF Report Here to get an idea of the overall scope of the full report.

Continue Reading

Preview

来源: PRNewswire

Technavio has announced its latest market research report titled Global Rapid Plasma Reagin Test Market 2022-2026

The global rapid plasma reagin test market is fragmented due to the presence of several prominent vendors. The established vendors have a sizeable market presence. They are continuously innovating their product offerings, which is enabling them to compete with larger players more effectively, intensifying competition in the market. The increasing regulatory standards and high capital requirements associated with RPR tests are reducing the entry of new players into the market.

The report considers Abbott Laboratories, Anamol Laboratories Pvt. Ltd., ARKRAY Inc., Arlington Scientific Inc., Atlas Medical GmbH, Becton Dickinson and Co., Bio Rad Laboratories Inc., Cardinal Health Inc., F. Hoffmann La Roche Ltd., Innovatek Medical Inc., Lorne Laboratories Ltd., Mediclone Biotech, Newmarket Biomedical Ltd., Novacyt SA, Sclavo Diagnostics International S.r.l., Sekisui Chemical Co. Ltd., and Thermo Fisher Scientific Inc. as major market participants. Although the increasing incidence of syphilis will offer immense growth opportunities, ensuring quality control for syphilis testing will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Request Sample Report Here

The global rapid plasma reagin test market is segmented as below:

Type

Rapid Plasma Reagin Test Kits

Analyzers and Instruments

Reagents

The market growth in the rapid plasma regain test kits segment will be significant during the forecast period. The segment is driven by the growing availability of RPR test kits and the high use of assays.

Geography

North America

Europe

Asia

Rest Of World (ROW)

North America is the largest market for rigid plasma reagin, occupying 54% of the global market share. The regional market is driven by the presence of a large number of vendors that offer RPR test kits, analyzers and instruments, and reagents. Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. Our rapid plasma reagin test market report covers the following areas:

Rapid Plasma Reagin Test Market Size

Rapid Plasma Reagin Test Market Trends

Rapid Plasma Reagin Test Market Industry Analysis

Rapid Plasma Reagin Test Market 2022-2026: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the rapid plasma reagin test market. Backed with competitive intelligence and benchmarking, our research report on the rapid plasma reagin test market is designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

Rapid Plasma Reagin Test Market 2022-2026: Key Highlights

CAGR of the market during the forecast period 2022-2026

Detailed information on factors that will assist rapid plasma reagin test market growth during the next five years

Estimation of the rapid plasma reagin test market size and its contribution to the parent market

Predictions on upcoming trends and changes in consumer behavior

The growth of the rapid plasma reagin test market

Analysis of the market's competitive landscape and detailed information on vendors

Comprehensive details of factors that will challenge the growth of rapid plasma reagin test market vendors

Related Reports:

Plasma Therapeutics Market by Product and Geography - Forecast and Analysis 2022-2026

Plasma Protease C1 Inhibitor Market by Product and Geography - Forecast and Analysis 2022-2026

Table Of Contents:

1 Executive Summary

1.1 Market overview

Exhibit 01: Executive Summary – Chart on Market Overview

Exhibit 02: Executive Summary – Data Table on Market Overview

Exhibit 03: Executive Summary – Chart on Global Market Characteristics

Exhibit 04: Executive Summary – Chart on Market by Geography

Exhibit 05: Executive Summary – Chart on Market Segmentation by Test

Exhibit 06: Executive Summary – Chart on Incremental Growth

Exhibit 07: Executive Summary – Data Table on Incremental Growth

Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem

Exhibit 09: Parent market

Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition

Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis

Exhibit 12: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026

Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)

Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)

Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)

Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary

Exhibit 17: Five forces analysis - Comparison between2021 and 2026

4.2 Bargaining power of buyers

Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers

Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants

Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes

Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry

Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition

Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Test

5.1 Market segments

Exhibit 24: Chart on Test - Market share 2021-2026 (%)

Exhibit 25: Data Table on Test - Market share 2021-2026 (%)

5.2 Comparison by Test

Exhibit 26: Chart on Comparison by Test

Exhibit 27: Data Table on Comparison by Test

5.3 Rapid plasma reagin test kits - Market size and forecast 2021-2026

Exhibit 28: Chart on Rapid plasma reagin test kits - Market size and forecast 2021-2026 ($ million)

Exhibit 29: Data Table on Rapid plasma reagin test kits - Market size and forecast 2021-2026 ($ million)

Exhibit 30: Chart on Rapid plasma reagin test kits - Year-over-year growth 2021-2026 (%)

Exhibit 31: Data Table on Rapid plasma reagin test kits - Year-over-year growth 2021-2026 (%)

5.4 Analyzers and instruments - Market size and forecast 2021-2026

Exhibit 32: Chart on Analyzers and instruments - Market size and forecast 2021-2026 ($ million)

Exhibit 33: Data Table on Analyzers and instruments - Market size and forecast 2021-2026 ($ million)

Exhibit 34: Chart on Analyzers and instruments - Year-over-year growth 2021-2026 (%)

Exhibit 35: Data Table on Analyzers and instruments - Year-over-year growth 2021-2026 (%)

5.5 Reagents - Market size and forecast 2021-2026

Exhibit 36: Chart on Reagents - Market size and forecast 2021-2026 ($ million)

Exhibit 37: Data Table on Reagents - Market size and forecast 2021-2026 ($ million)

Exhibit 38: Chart on Reagents - Year-over-year growth 2021-2026 (%)

Exhibit 39: Data Table on Reagents - Year-over-year growth 2021-2026 (%)

5.6 Market opportunity by Test

Exhibit 40: Market opportunity by Test ($ million)

6 Customer Landscape

6.1 Customer landscape overview

Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation

Exhibit 42: Chart on Market share by geography 2021-2026 (%)

Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

7.2 Geographic comparison

Exhibit 44: Chart on Geographic comparison

Exhibit 45: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026

Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)

Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)

Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)

Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Europe - Market size and forecast 2021-2026

Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)

Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)

Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)

Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.5 Asia - Market size and forecast 2021-2026

Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)

Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)

Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)

Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026

Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)

Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)

Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026

Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)

Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)

Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)

Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 France - Market size and forecast 2021-2026

Exhibit 66: Chart on France - Market size and forecast 2021-2026 ($ million)

Exhibit 67: Data Table on France - Market size and forecast 2021-2026 ($ million)

Exhibit 68: Chart on France - Year-over-year growth 2021-2026 (%)

Exhibit 69: Data Table on France - Year-over-year growth 2021-2026 (%)

7.9 China - Market size and forecast 2021-2026

Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)

Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)

Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)

Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)

7.10 Canada - Market size and forecast 2021-2026

Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)

Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)

Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)

Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

7.11 Germany - Market size and forecast 2021-2026

Exhibit 78: Chart on Germany - Market size and forecast 2021-2026 ($ million)

Exhibit 79: Data Table on Germany - Market size and forecast 2021-2026 ($ million)

Exhibit 80: Chart on Germany - Year-over-year growth 2021-2026 (%)

Exhibit 81: Data Table on Germany - Year-over-year growth 2021-2026 (%)

7.12 Market opportunity by geography

Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges

Exhibit 83: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape

Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption

Exhibit 85: Overview on factors of disruption

9.4 Industry risks

Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered

Exhibit 87: Vendors covered

10.2 Market positioning of vendors

Exhibit 88: Matrix on vendor position and classification

10.3 Abbott Laboratories

Exhibit 89: Abbott Laboratories - Overview

Exhibit 90: Abbott Laboratories - Business segments

Exhibit 91: Abbott Laboratories - Key news

Exhibit 92: Abbott Laboratories - Key offerings

Exhibit 93: Abbott Laboratories - Segment focus

10.4 Arlington Scientific Inc.

Exhibit 94: Arlington Scientific Inc. - Overview

Exhibit 95: Arlington Scientific Inc. - Product / Service

Exhibit 96: Arlington Scientific Inc. - Key offerings

10.5 Becton Dickinson and Co.

Exhibit 97: Becton Dickinson and Co. - Overview

Exhibit 98: Becton Dickinson and Co. - Business segments

Exhibit 99: Becton Dickinson and Co. - Key news

Exhibit 100: Becton Dickinson and Co. - Key offerings

Exhibit 101: Becton Dickinson and Co. - Segment focus

10.6 Bio Rad Laboratories Inc.

Exhibit 102: Bio Rad Laboratories Inc. - Overview

Exhibit 103: Bio Rad Laboratories Inc. - Business segments

Exhibit 104: Bio Rad Laboratories Inc. - Key news

Exhibit 105: Bio Rad Laboratories Inc. - Key offerings

Exhibit 106: Bio Rad Laboratories Inc. - Segment focus

10.7 Cardinal Health Inc.

Exhibit 107: Cardinal Health Inc. - Overview

Exhibit 108: Cardinal Health Inc. - Business segments

Exhibit 109: Cardinal Health Inc. - Key news

Exhibit 110: Cardinal Health Inc. - Key offerings

Exhibit 111: Cardinal Health Inc. - Segment focus

10.8 F. Hoffmann La Roche Ltd.

Exhibit 112: F. Hoffmann La Roche Ltd. - Overview

Exhibit 113: F. Hoffmann La Roche Ltd. - Business segments

Exhibit 114: F. Hoffmann La Roche Ltd. - Key news

Exhibit 115: F. Hoffmann La Roche Ltd. - Key offerings

Exhibit 116: F. Hoffmann La Roche Ltd. - Segment focus

10.9 Novacyt SA

Exhibit 117: Novacyt SA - Overview

Exhibit 118: Novacyt SA - Business segments

Exhibit 119: Novacyt SA - Key offerings

Exhibit 120: Novacyt SA - Segment focus

10.10 Sclavo Diagnostics International S.r.l.

Exhibit 121: Sclavo Diagnostics International S.r.l. - Overview

Exhibit 122: Sclavo Diagnostics International S.r.l. - Product / Service

Exhibit 123: Sclavo Diagnostics International S.r.l. - Key offerings

10.11 Sekisui Chemical Co. Ltd.

Exhibit 124: Sekisui Chemical Co. Ltd. - Overview

Exhibit 125: Sekisui Chemical Co. Ltd. - Business segments

Exhibit 126: Sekisui Chemical Co. Ltd. - Key offerings

Exhibit 127: Sekisui Chemical Co. Ltd. - Segment focus

10.12 Thermo Fisher Scientific Inc.

Exhibit 128: Thermo Fisher Scientific Inc. - Overview

Exhibit 129: Thermo Fisher Scientific Inc. - Business segments

Exhibit 130: Thermo Fisher Scientific Inc. - Key news

Exhibit 131: Thermo Fisher Scientific Inc. - Key offerings

Exhibit 132: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist

Exhibit 133: Inclusions checklist

Exhibit 134: Exclusions checklist

11.3 Currency conversion rates for US$

Exhibit 135: Currency conversion rates for US$

11.4 Research methodology

Exhibit 136: Research methodology

Exhibit 137: Validation techniques employed for market sizing

Exhibit 138: Information sources

11.5 List of abbreviations

Exhibit 139: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]

Website: www.technavio.com/

SOURCE Technavio

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。